Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression.

Source:http://linkedlifedata.com/resource/pubmed/id/16091761

Br. J. Cancer 2005 Sep 5 93 5 544-51

Download in:

View as

General Info

PMID
16091761